Immuron Receives U.S. Patent on Drug Composition to Treat Clostridium difficile C. difficile remains a major medical problem, causing an estimated annual economic burden of more than USD $10 billion globally, with 28,000 deaths per year in the U.S. alone U.S. Patent Office issues...